LataMed AI is trading 6.04% up at $0.51 as investors continue reacting to its August 19 announcement that its mobile healthcare application entered final testing.
- Apple App Store and Google Play submissions are expected in the coming weeks, subject to platform review.
- No newer August 26 company announcement was identified; broader markets were essentially flat, leaving the app milestone as the clearest catalyst.